Introduction
Autism Spectrum Disorder (ASD) is a common disorder which effects children's development of language and social skills. About 1 in 68 children has been diagnosed with autism spectrum disorder acording to the Centers for Disease Control and Prevention (CDC) datas (Centers for Disease Control and Prevention (CDC), 2014). Psychiatric comorbidities are common in children with ASD. Anxiety disorders also shows high comorbidity in children with ASD (Van Steensel, Francisca, Bögels, & Bruin, 2013) .
Some guidlines recommend selective serotonin reuptake inhibitors (SSRIs) as first line treatment for anxiety disorders (Bandelow, Zohar, Hollander, Kasper, & Möller, 2008) . SSRIs are also effective in the treatment of autistic individuals with anxiety disorders (Alexander, Mathewson, & Hollander, 2006) . Use of atypical antipscyhotics to augment antianxiety medication has been shown to be beneficial in the treatment of anxiety (Rynn et al., 2011) As far as we know this is the first reported case of an autistic child with seperation anxiety disorder treated with low dose aripiprazole.
Case Report
The case presented here was a severn year-old boy consulted our clinic with complaints of can not staying alone, having an exessive fear in sleeping alone without his mother, and slight hyperactivity. He can not speak except few words, such as mother, father, and water. According to his mother, he had an exessive fear when she had gone away altough some close relatives with the side of him. In these situations, he had crying and hurting (American Psychiatric Association, 2013) . Clinical Global Index (CGI) score of anxiety symptoms was seven at the begining of treatment. Aripiprazole 2.5 mg/day was initiated and two weeks later, anxiety symptoms slight improved and CGI score was five at this visit. Aripiprazole doze increased to 5 mg/day and one month later the patient's anxiety symptoms had decreased, and his CGI score was one and his hyperactivite was also improved and anxiety symptoms never recurred over two months of follow-up.
Discussion
Treatment of anxiety with SSRIs is wellknown. Some studies showed the beneficial results of augmentation of therapeutic effect of SSRIs by adding an aripiprazole in the treatment of obsessive compulsive disease (OCD) and depression (Akyol-Ardic et al., 2016; Sugawara, Sakamoto, Harada, Shimizu, & Ishigooka, 2016) . Also aripiprazole monotherapy effective in the treatment of OCD (Connor, Payne, Gadde, Zhang, & Davidson, 2005) . Low dose aripiprazole brought about improvement in anxiety symptoms in our case.
Future studies investigating the antipscyotic monotheraphy on anxiety disorders will improve our knowledge of this topic.
